An Ozempic-like medication is set to be listed on the Pharmaceutical Benefits Scheme shortly, saving patients with "severe" obesity and cardiovascular disease thousands of dollars even as the government warns it will lump taxpayers with a "very big bill"
Research where higher per-mg total cost is acceptable
GLP-1 agonists are more effective than placebo in HbA1c reduction, Z = 5.27, SMD, 0.23, 95% confidence interval (CI), 0.140.32, with 1.2 mg and 1.8 mg more effective than 0.6 mg, SMD, 0.87, 95% CI, 1.60 to 0.13, and SMD, 0.79, 95% CI, 1.18 to 0.41, respectively
When used as directed, InfiniWell BPC-157 Rapid Pro is generally well tolerated
Semaglutide injections and oral tablets work through the same mechanism, so reflux risk is comparable
Peptide research brief DSIP (Delta Sleep-Inducing Peptide): sleep-architecture research and mechanism uncertainty Common name DSIP (Delta Sleep-Inducing Peptide) Classification Endogenous nonapeptide